![Joe Hsueh](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joe Hsueh
Founder at Act Genomics Co. Ltd.
Joe Hsueh active positions
Companies | Position | Start | End |
---|---|---|---|
TaiGen Biotechnology Co., Ltd.
![]() TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Chief Operating Officer | 01/10/2012 | - |
Corporate Officer/Principal | 31/12/2000 | 01/10/2012 | |
Act Genomics Co. Ltd.
![]() Act Genomics Co. Ltd. Hospital/Nursing ManagementHealth Services ACT Genomics Co. Ltd. develops cancer molecular information and therapeutic solutions. It specializes in oncology, cancer genomics, and bioinformatics. The company was founded by Shu Jen Chen and Hua Chien Chen in 2014 and is headquartered in Taipei, Taiwan. | Chief Operating Officer | - | - |
Founder | - | - | |
AnBogen Therapeutics, Inc.
![]() AnBogen Therapeutics, Inc. BiotechnologyHealth Technology AnBogen Therapeutics, Inc. is a clinical-stage biotech company based in Taiwan. AnBogen Therapeutics is dedicated to designing and developing precision oncology therapies to improve the lives of patients. The Taiwanese company aims to bridge the gap between research and clinical development and create breakthrough science that meaningfully changes the lives of patients. AnBogen Therapeutics' collective experience in medicinal chemistry, cancer biology, drug discovery, and clinical development enables the development of a differentiated pipeline in the field of precision oncology. AnBogen Therapeutics, Inc. was founded by a group of scientists from the National Health Research Institute. The company was founded by Tsu-An Hsu, who has been the CEO since incorporation. | President | - | - |
Career history of Joe Hsueh
Training of Joe Hsueh
Soochow University | Undergraduate Degree |
Fairleigh Dickinson University | Masters Business Admin |
Statistics
International
Taiwan | 4 |
China | 2 |
United States | 2 |
Operational
Chief Operating Officer | 2 |
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 3 |
Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 3 |
---|---|
TaiGen Biotechnology Co., Ltd.
![]() TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Health Technology |
Act Genomics Co. Ltd.
![]() Act Genomics Co. Ltd. Hospital/Nursing ManagementHealth Services ACT Genomics Co. Ltd. develops cancer molecular information and therapeutic solutions. It specializes in oncology, cancer genomics, and bioinformatics. The company was founded by Shu Jen Chen and Hua Chien Chen in 2014 and is headquartered in Taipei, Taiwan. | Health Services |
AnBogen Therapeutics, Inc.
![]() AnBogen Therapeutics, Inc. BiotechnologyHealth Technology AnBogen Therapeutics, Inc. is a clinical-stage biotech company based in Taiwan. AnBogen Therapeutics is dedicated to designing and developing precision oncology therapies to improve the lives of patients. The Taiwanese company aims to bridge the gap between research and clinical development and create breakthrough science that meaningfully changes the lives of patients. AnBogen Therapeutics' collective experience in medicinal chemistry, cancer biology, drug discovery, and clinical development enables the development of a differentiated pipeline in the field of precision oncology. AnBogen Therapeutics, Inc. was founded by a group of scientists from the National Health Research Institute. The company was founded by Tsu-An Hsu, who has been the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Joe Hsueh
- Experience